Jaguar Health (JAGX) EPS (Diluted) (QoQ) (2020 - 2026)
Jaguar Health (JAGX) EPS (Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.09% |
| Dec 31, 2025 | -55.96% |
| Sep 30, 2025 | 38.73% |
| Jun 30, 2025 | 37.68% |
| Mar 31, 2025 | 51.94% |
| Dec 31, 2024 | -29.97% |
| Sep 30, 2024 | 73.53% |
| Jun 30, 2024 | -15.95% |
| Mar 31, 2024 | 85.40% |
| Dec 31, 2023 | -6.08% |
| Sep 30, 2023 | 10.05% |
| Jun 30, 2023 | 82.60% |
| Mar 31, 2023 | 58.52% |
| Dec 31, 2022 | 34.60% |
| Sep 30, 2022 | 0.99% |
| Jun 30, 2022 | 71.36% |
| Mar 31, 2022 | -25.66% |
| Dec 31, 2021 | -28.07% |
| Sep 30, 2021 | 20.63% |
| Jun 30, 2021 | -17.25% |